EP 0661977 A4 19941020 - TREATMENT OF COLORECTAL CANCER.
Title (en)
TREATMENT OF COLORECTAL CANCER.
Title (de)
BEHANDLUNG VON KOLOREKTALER KREBS.
Title (fr)
TRAITEMENT DU CANCER COLO-RECTAL.
Publication
Application
Priority
- US 9206131 W 19920724
- US 80457091 A 19911210
Abstract (en)
[origin: WO9311770A1] A method of treating colorectal cancer in a human afflicted therewith which comprises administering to such human an effective amount of a compound of the water soluble camptothecin analog class.
IPC 1-7
A61K 31/535; A61K 31/50; A61K 31/44; A61K 31/495; A61K 31/47
IPC 8 full level
A61K 31/47 (2006.01); A61K 31/495 (2006.01); A61K 31/535 (2006.01); A61P 35/00 (2006.01); C07D 491/22 (2006.01)
CPC (source: EP)
A61K 31/47 (2013.01); A61K 31/495 (2013.01); A61K 31/535 (2013.01); A61P 35/00 (2017.12)
Citation (search report)
- [DX] EP 0321122 A2 19890621 - SMITHKLINE BECKMAN CORP [US]
- [X] M.R. MATTERN ET AL: "Synergistig cell killing by ionizing radiation and topoisomerase I inhibitor SKF 104864.", PROC. AM. ASSOC. CANCER RES. ANNU. MEET., vol. 31, no. 0, 1990, pages 436
- [X] H BURRIS ET AL.: "SKF 104864: preclinical studies of a new topoisomerase I inhibitor.", PROC. AM. ASSOC. CANCER RES. ANNU. MEET., vol. 31, no. 0, 1990, pages 431
- See references of WO 9311770A1
Designated contracting state (EPC)
AT BE CH DE DK ES FR GB GR IT LI LU MC NL SE
DOCDB simple family (publication)
WO 9311770 A1 19930624; AU 2394392 A 19930719; CA 2125293 A1 19930624; EP 0661977 A1 19950712; EP 0661977 A4 19941020; JP H07501818 A 19950223; MX 9205766 A 19930601; PT 100948 A 19940131
DOCDB simple family (application)
US 9206131 W 19920724; AU 2394392 A 19920724; CA 2125293 A 19920724; EP 92916470 A 19920724; JP 51086393 A 19920724; MX 9205766 A 19921008; PT 10094892 A 19921009